Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1565357

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1565357

At-Home Blood Collection Devices Market by Product, Sample Type, Collection Method, Device Type, Application - Global Forecast to 2029

PUBLISHED:
PAGES: 269 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The valuation of the at-home blood collection devices market in 2024 is USD 93 million and this market is projected to reach USD 135 million by 2029, growing at a CAGR of 7.6% for the period from 2024 to 2029. High demand for at-home blood collection & microsampling devices is primarily on account of rising infectious diseases, chronic disorders, and lifestyle-related diseases.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsProduct, collection method, sample type, usability, device type, and application
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries

Pathogenic microorganisms, a continuous danger to public health, have been a major threat and reason for many deathly infectious diseases causing outbreaks all over the world. Periodic monitoring of the viral load, antibodies, and other biomarkers is necessary in infectious diseases like HIV/AIDS, hepatitis, and new viral outbreaks to trace the progression of disease and effectiveness of treatment.

At-home blood collection devices are functional because they allow patients to collect blood samples within their environment, which reduces exposure in healthcare settings and allows for timely testing. The ease of use, privacy, and convenience are what drives this trend with the at-home blood collection device. Hence, due to increased infectious diseases cases, it should boost the growth and adoption of at-home blood collection kits.

"Fingerstick method segment has taken the larger portion of the at-home blood collection devices market, by collection method, during the forecast period."

The at-home blood collection devices market can be segmented, based on the collection method, into fingerstick, push-button, and other sample collection methods. In 2023, the fingerstick method held the major share of the at-home blood collection devices market. Moreover, broad acceptance of fingerstick has been attributed to compliance with regulatory standards that ascertains additional safety and reliability for its use at home. This further consolidates its leading position on the market, as it can easily find its place within daily routine and allow regular health monitoring without professional interventions.

"Liquid samples segment accounted for the highest growth rate in the at-home blood collection devices market, by sample type, during the forecast period."

The at-home blood collection devices market is further divided into liquid and dried samples based on the type of sample. Liquid blood samples are expected to grow at a higher CAGR in the at-home blood collection devices market as compared to dried samples, due to their superior performance for delivering accurate and immediate diagnostic results. Compared to a dried sample that is to be rehydrated and its problems of stability and degradation, liquid blood samples are way more reliable for the same purpose. Another reason blood in its liquid form is becoming more favored is that it is easier to collect enough volume to perform a wide variety of tests, and technological advances make this process easy to conduct and relatively painless. It is foreseen that liquid blood samples will continue to see rapid market growth due to their support for advanced testing methodologies and an increasing demand for real-time health monitoring.

"Asia Pacific: The fastest-growing region in at-home blood collection devices market."

The worldwide market for at-home blood collection devices is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the at-home blood collection devices market. Increasing collaborations between academic institutions, research organizations, and healthcare companies in the Asia Pacific region contribute to the advancement and commercialization of at-home blood collection devices technologies.

Rapid urbanization and growing disposable incomes have resulted in increased investments in healthcare and growing consumer demand for convenient health monitoring solutions.

The break-up of the profile of primary participants in the at-home blood collection devices market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in this market are Trajan Group Holdings Limited (Australia), Tasso, Inc. (US), YourBio Health, Inc. (US), A. Menarini Diagnostics (UK), R-Biopharm AG (Germany), Sussex Pathology Limited (UK), ImmunoServ (UK), Labonovum (Netherlands), Alpha Laboratories (UK), Lipomic Healthcare (India), Tri-Tech Forensics (US), RDA Spot Inc (Lithuania), Spot On Sciences (US), Capitainer (Sweden), PanoHealth (US), Lameditech (South Korea), Sara Healthcare (India), Owen Mumford Ltd (UK), RedDrop Dx, Inc. (US), AdvaCare Pharma (US), Naulakha Industries (India), and Phoenix Healthcare Solutions, LLC (US).

Research Coverage:

This research report categorizes the at-home blood collection devices market by product (Fingerstick Blood Collection Kits, DBS Collection Kits, Lancets, Other Products), by collection methods (Fingerstick Method, Push-button Method, Other Methods), by usability (Single-use Blood Collection Devices and Reusable Blood Collection Devices), by sample type (Dried Blood Samples and Liquid Blood Samples), by device type (Self-collection Devices and Professional Collection Devices), by application (Disease Diagnostics, Health Screening & Preventive Health, Clinical Trials & Research, Other Applications), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the at-home blood collection devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the at-home blood collection devices market. Competitive analysis of upcoming startups in the at-home blood collection devices market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall at-home blood collection devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing burden of chronic disorders and lifestyle-related health conditions, Increasing prevalence of infectious diseases, Rising geriatric population and incidence of age-associated diseases, and Rising demand for painless devices and growing technological advancements), opportunities (Growth opportunities in emerging economies), restraints (Unregulated use of products for at-home blood collection and Pricing pressure owing to reimbursement cuts and budget constraints), and challenges (Inadequate access to microsampling devices in resource-limited areas) influencing the growth of the at-home blood collection devices market market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the at-home blood collection devices market market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the at-home blood collection devices market market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the at-home blood collection devices market market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Tasso, Inc. (US), Trajan Group Holdings Limited (Australia), YourBio Health, Inc. (US), Capitainer (Sweden), and A. Menarini Diagnostics s.r.l (UK).
Show more
Product Code: MD 9125

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 RISK ASSESSMENT
    • 2.8.1 RISK ASSESSMENT: AT-HOME BLOOD COLLECTION DEVICES MARKET
  • 2.9 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 AT-HOME BLOOD COLLECTION DEVICES MARKET OVERVIEW
  • 4.2 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2024 VS. 2029
  • 4.3 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2024 VS. 2029
  • 4.4 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2024 VS. 2029
  • 4.5 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029
  • 4.6 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2024 VS. 2029
  • 4.7 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2024 VS. 2029
  • 4.8 AT-HOME BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing burden of chronic disorders and lifestyle-related health conditions
      • 5.2.1.2 Increasing prevalence of infectious diseases
      • 5.2.1.3 Rising geriatric population and incidence of age-associated diseases
      • 5.2.1.4 Rising demand for painless devices and growing technological advancements
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unregulated use of products for at-home blood collection
      • 5.2.2.2 Pricing pressure owing to reimbursement cuts and budget constraints
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Inadequate access to microsampling devices in resource-limited areas
  • 5.3 PRICING ANALYSIS
  • 5.4 PATENT ANALYSIS
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR LANCETS, CANNULAS, AND CATHETERS
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 AT-HOME BLOOD COLLECTION DEVICES MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 BUYING CRITERIA
  • 5.11 REGULATORY LANDSCAPE
    • 5.11.1 NORTH AMERICA
      • 5.11.1.1 US
      • 5.11.1.2 Canada
    • 5.11.2 EUROPE
    • 5.11.3 ASIA PACIFIC
      • 5.11.3.1 China
      • 5.11.3.2 Japan
      • 5.11.3.3 India
    • 5.11.4 LATIN AMERICA
      • 5.11.4.1 Brazil
      • 5.11.4.2 Mexico
    • 5.11.5 MIDDLE EAST
      • 5.11.5.1 Africa
    • 5.11.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 TECHNOLOGY ANALYSIS
    • 5.12.1 KEY TECHNOLOGIES
      • 5.12.1.1 Lancets
    • 5.12.2 COMPLEMENTARY TECHNOLOGIES
      • 5.12.2.1 Dried Blood Spot Collection
    • 5.12.3 ADJACENT TECHNOLOGIES
      • 5.12.3.1 Laser Lancets
  • 5.13 KEY CONFERENCES AND EVENTS IN 2024-2025
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 ASSESSING DIAGNOSTIC ACCURACY OF VOLUMETRIC ABSORPTIVE MICROSAMPLING COMPARED TO GOLD STANDARD METHOD
  • 5.17 IMPACT OF AI ON AT-HOME BLOOD COLLECTION DEVICES MARKET

6 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 LANCETS
    • 6.2.1 HIGH AFFORDABILITY AND FREQUENT USE TO DRIVE UPTAKE OF LANCETS
  • 6.3 DRIED BLOOD SPOT COLLECTION KITS
    • 6.3.1 SUPPORT FOR SHORT-TERM STORAGE TO DRIVE MARKET
  • 6.4 FINGERSTICK BLOOD COLLECTION KITS
    • 6.4.1 DEMAND FOR PAINLESS TECHNOLOGIES TO HAMPER MARKET GROWTH
  • 6.5 OTHER PRODUCTS

7 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE

  • 7.1 INTRODUCTION
    • 7.1.1 PRIMARY NOTES
  • 7.2 LIQUID BLOOD SAMPLES
    • 7.2.1 FAVORABLE REGULATORY AND INVESTMENT LANDSCAPES TO DRIVE ADOPTION
  • 7.3 DRIED BLOOD SAMPLES
    • 7.3.1 EASY COLLECTION AND REDUCED REQUIREMENT FOR COLD STORAGE TO SUPPORT UPTAKE OF DRIED BLOOD-BASED DEVICES

8 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD

  • 8.1 INTRODUCTION
  • 8.2 FINGERSTICK SAMPLE COLLECTION
    • 8.2.1 HIGH AFFORDABILITY AND ACCESSIBILITY TO DRIVE MARKET
  • 8.3 PUSH-BUTTON SAMPLE COLLECTION
    • 8.3.1 CONSISTENCY AND RELIABILITY TO SUPPORT HOME-USE ADOPTION
  • 8.4 OTHER SAMPLE COLLECTION METHODS

9 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE

  • 9.1 INTRODUCTION
  • 9.2 SELF-COLLECTION DEVICES
    • 9.2.1 INCREASED PRIVACY AND CONFIDENTIALITY OF SELF-COLLECTION DEVICES TO DRIVE MARKET
  • 9.3 PROFESSIONAL COLLECTION DEVICES
    • 9.3.1 GROWING AWARENESS AND USAGE OF SELF-COLLECTION DEVICES TO HINDER ADOPTION

10 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY

  • 10.1 INTRODUCTION
  • 10.2 SINGLE-USE BLOOD COLLECTION DEVICES
    • 10.2.1 INCREASED AFFORDABILITY OF SINGLE-USE DEVICES TO DRIVE ADOPTION
  • 10.3 REUSABLE BLOOD COLLECTION DEVICES
    • 10.3.1 NEED FOR PAINLESS TECHNOLOGIES TO PROPEL UPTAKE

11 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
  • 11.2 HEALTH SCREENING & PREVENTIVE HEALTH
    • 11.2.1 GROWING AWARENESS ON REGULAR HEALTH ASSESSMENTS TO FUEL MARKET GROWTH
  • 11.3 DISEASE DIAGNOSTICS
    • 11.3.1 INCREASING DEMAND FOR EARLY DISEASE DETECTION TO DRIVE MARKET
  • 11.4 CLINICAL TRIALS & RESEARCH
    • 11.4.1 NEED FOR COMPREHENSIVE & STANDARDIZED RESEARCH FINDINGS TO PROPEL MARKET GROWTH
  • 11.5 OTHER APPLICATIONS

12 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 Advanced infrastructure and high healthcare expenditure to drive market
    • 12.2.2 CANADA
      • 12.2.2.1 Rising prevalence of kidney diseases to propel demand
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Increasing healthcare expenditure to propel market
    • 12.3.2 UK
      • 12.3.2.1 Increasing prevalence of lifestyle diseases to drive market
    • 12.3.3 FRANCE
      • 12.3.3.1 Rising R&D expenditure to provide growth opportunities
    • 12.3.4 ITALY
      • 12.3.4.1 Growing diabetes prevalence to sustain demand for testing
    • 12.3.5 SPAIN
      • 12.3.5.1 Growth in elderly demographics in Spain to propel market
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 China to hold largest share of APAC market
    • 12.4.2 JAPAN
      • 12.4.2.1 Well-established healthcare system to support market
    • 12.4.3 INDIA
      • 12.4.3.1 Large patient population and rising prevalence of chronic diseases to drive market
    • 12.4.4 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Brazil to dominate LATAM market
    • 12.5.2 MEXICO
      • 12.5.2.1 Rising prevalence of chronic diseases to drive market
    • 12.5.3 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
  • 12.7 GCC COUNTRIES
    • 12.7.1 INFRASTRUCTURAL DEVELOPMENT AND GROWING DISEASE INCIDENCE TO DRIVE MARKET

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET
  • 13.3 REVENUE SHARE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Product footprint
      • 13.5.5.3 Regional footprint
      • 13.5.5.4 Application footprint
      • 13.5.5.5 Sample type footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, 2023
  • 13.7 VALUATION & FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
    • 13.8.1 SARA HEALTHCARE
    • 13.8.2 OWEN MUMFORD
    • 13.8.3 A. MENARINI DIAGNOSTICS S.R.L
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 TASSO, INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product approvals
        • 14.1.1.3.2 Deals
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 TRAJAN GROUP HOLDINGS LIMITED
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
        • 14.1.2.3.2 Other developments
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses & competitive threats
    • 14.1.3 YOURBIO HEALTH, INC.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product approvals
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses & competitive threats
    • 14.1.4 CAPITAINER
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches
        • 14.1.4.3.2 Deals
        • 14.1.4.3.3 Other developments
    • 14.1.5 A. MENARINI DIAGNOSTICS S.R.L (MENARINI GROUP)
      • 14.1.5.1 Business overview
    • 14.1.6 R-BIOPHARM AG
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
    • 14.1.7 SUSSEX PATHOLOGY LIMITED
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
    • 14.1.8 IMMUNOSERV
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
    • 14.1.9 LABONOVUM
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
    • 14.1.10 ALPHA LABORATORIES
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
    • 14.1.11 LIPOMIC HEALTHCARE
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
    • 14.1.12 TRI-TECH FORENSICS
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 RDA SPOT INC.
    • 14.2.2 SPOT ON SCIENCES
    • 14.2.3 PANOHEALTH
    • 14.2.4 LAMEDITECH
    • 14.2.5 SARA HEALTHCARE
    • 14.2.6 OWEN MUMFORD LTD
    • 14.2.7 REDDROP DX, INC.
    • 14.2.8 ADVACARE PHARMA
    • 14.2.9 NAULAKHA INDUSTRIES
    • 14.2.10 PHOENIX HEALTHCARE SOLUTIONS, LLC

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
Show more
Product Code: MD 9125

List of Tables

  • TABLE 1 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION (2022 VS 2030 VS 2050)
  • TABLE 2 INDICATIVE PRICING OF KEY PLAYERS, BY PRODUCT
  • TABLE 4 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 5 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 6 AT-HOME BLOOD COLLECTION DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF AT-HOME BLOOD COLLECTION DEVICES (%)
  • TABLE 8 KEY BUYING CRITERIA FOR AT-HOME BLOOD COLLECTION DEVICES
  • TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 10 EUROPE: CLASSIFICATION OF DEVICES
  • TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 AT-HOME BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2024-2025
  • TABLE 18 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 19 COMMERCIALLY AVAILABLE LANCETS, BY COMPANY
  • TABLE 20 LANCETS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 21 NORTH AMERICA: LANCETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 22 EUROPE: LANCETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 23 ASIA PACIFIC: LANCETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 LATIN AMERICA: LANCETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 25 COMMERCIALLY AVAILABLE DBS COLLECTION KITS, BY COMPANY
  • TABLE 26 DBS COLLECTION KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 27 NORTH AMERICA: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 EUROPE: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 LATIN AMERICA: DBS COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 FINGERSTICK BLOOD COLLECTION KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 NORTH AMERICA: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 EUROPE: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 LATIN AMERICA: FINGERSTICK BLOOD COLLECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 37 NORTH AMERICA: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 EUROPE: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, 2022-2029 (USD MILLION)
  • TABLE 40 LATIN AMERICA: OTHER AT-HOME BLOOD COLLECTION PRODUCTS MARKET, 2022-2029 (USD MILLION)
  • TABLE 41 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 42 LIQUID BLOOD SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 43 AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 EUROPE: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: AT-HOME LIQUID BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 DRIED BLOOD SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 49 COMPARATIVE ANALYSIS: DRIED BLOOD SPOT VS. CONVENTIONAL SAMPLES (WHOLE BLOOD, SERUM, AND PLASMA)
  • TABLE 50 AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 EUROPE: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: AT-HOME DRIED BLOOD SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 56 FINGERSTICK SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 57 AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 EUROPE: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: AT-HOME FINGERSTICK BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 PUSH-BUTTON SAMPLE COLLECTION: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 63 AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 EUROPE: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 LATIN AMERICA: AT-HOME PUSH-BUTTON BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER SAMPLE COLLECTION METHODS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 AT-HOME SELF-COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 EUROPE: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 LATIN AMERICA: AT-HOME SELF-COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 EUROPE: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: AT-HOME PROFESSIONAL COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 85 SINGLE-USE DEVICES: COMMERCIALLY AVAILABLE PRODUCTS, BY COMPANY
  • TABLE 86 SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 LATIN AMERICA: SINGLE-USE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 REUSABLE BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 LATIN AMERICA: REUSABLE BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 97 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR HEALTH SCREENING & PREVENTIVE HEALTH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR CLINICAL TRIALS & RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 125 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 126 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 128 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 130 US: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 131 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 132 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 134 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 136 CANADA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 137 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 139 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 141 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 143 EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 144 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 145 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 147 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 149 GERMANY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 150 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 151 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 153 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 155 UK: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 156 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 157 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 159 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 161 FRANCE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 162 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 163 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 165 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 167 ITALY: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 168 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 169 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 171 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 173 SPAIN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 174 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 175 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 177 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 179 REST OF EUROPE: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 187 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 188 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 190 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 192 CHINA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 193 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 194 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 196 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 198 JAPAN: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 199 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 200 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 202 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 204 INDIA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 205 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 206 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 208 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 211 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 213 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 215 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 218 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 219 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 221 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 223 BRAZIL: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 224 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 225 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 227 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 229 MEXICO: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 230 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 231 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 233 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 235 REST OF LATIN AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 239 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 241 MIDDLE EAST & AFRICA: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 242 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2022-2029 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2022-2029 (USD MILLION)
  • TABLE 247 GCC COUNTRIES: AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 248 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 249 AT-HOME BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 250 AT-HOME BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 251 AT-HOME BLOOD COLLECTION DEVICES MARKET: REGIONAL FOOTPRINT
  • TABLE 252 AT-HOME BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT
  • TABLE 253 AT-HOME BLOOD COLLECTION DEVICES MARKET: SAMPLE TYPE FOOTPRINT
  • TABLE 254 AT-HOME BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 255 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • TABLE 256 AT-HOME BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 257 AT-HOME BLOOD COLLECTION DEVICES MARKET: DEALS, JANUARY 2021- JUNE 2024
  • TABLE 258 AT-HOME BLOOD COLLECTION DEVICES MARKET: EXPANSIONS, JANUARY 2021- JUNE 2024
  • TABLE 259 AT-HOME BLOOD COLLECTION DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021- JUNE 2024
  • TABLE 260 TASSO, INC.: COMPANY OVERVIEW
  • TABLE 261 TASSO, INC.: PRODUCTS OFFERED
  • TABLE 262 TASSO, INC.: PRODUCT APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 263 TASSO, INC.: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 264 TRAJAN GROUP HOLDINGS LIMITED: COMPANY OVERVIEW
  • TABLE 265 TRAJAN GROUP HOLDINGS LIMITED: PRODUCTS OFFERED
  • TABLE 266 TRAJAN GROUP HOLDINGS LIMITED: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 267 TRAJAN GROUP HOLDINGS LIMITED: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 268 YOURBIO HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 269 YOURBIO HEALTH, INC.: PRODUCTS OFFERED
  • TABLE 270 YOURBIO HEALTH, INC.: PRODUCT APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 271 CAPITAINER: COMPANY OVERVIEW
  • TABLE 272 CAPITAINER: PRODUCTS OFFERED
  • TABLE 273 CAPITAINER: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 274 CAPITAINER: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 275 CAPITAINER: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 276 A. MENARINI DIAGNOSTICS S.R.L.: COMPANY OVERVIEW
  • TABLE 277 A. MENARINI DIAGNOSTICS S.R.L.: PRODUCTS OFFERED
  • TABLE 278 R-BIOPHARM AG: COMPANY OVERVIEW
  • TABLE 279 R-BIOPHARM AG: PRODUCTS OFFERED
  • TABLE 280 SUSSEX PATHOLOGY LIMITED: COMPANY OVERVIEW
  • TABLE 281 SUSSEX PATHOLOGY LIMITED: PRODUCTS OFFERED
  • TABLE 282 SUSSEX PATHOLOGY LIMITED: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 283 IMMUNOSERV: COMPANY OVERVIEW
  • TABLE 284 IMMUNOSERV: PRODUCTS OFFERED
  • TABLE 285 LABONOVUM: COMPANY OVERVIEW
  • TABLE 286 LABONOVUM: PRODUCTS OFFERED
  • TABLE 287 ALPHA LABORATORIES: COMPANY OVERVIEW
  • TABLE 288 ALPHA LABORATORIES: PRODUCTS OFFERED
  • TABLE 289 LIPOMIC HEALTHCARE: COMPANY OVERVIEW
  • TABLE 290 LIPOMIC HEALTHCARE: PRODUCTS OFFERED
  • TABLE 291 TRI-TECH FORENSICS: COMPANY OVERVIEW
  • TABLE 292 TRI-TECH FORENSICS: PRODUCTS OFFERED

List of Figures

  • FIGURE 1 AT-HOME BLOOD COLLECTION DEVICES MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 6 AT-HOME BLOOD COLLECTION DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY COLLECTION METHOD, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY USABILITY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 AT-HOME BLOOD COLLECTION DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND LIFESTYLE-RELATED DISORDERS TO SUPPORT MARKET GROWTH
  • FIGURE 16 LANCETS TO DOMINATE MARKET TILL 2029
  • FIGURE 17 LIQUID BLOOD SAMPLES TO HOLD LARGEST MARKET SHARE
  • FIGURE 18 FINGERSTICK AND PUSH-BUTTON METHODS TO HOLD LARGER SHARES
  • FIGURE 19 SELF-COLLECTION DEVICES TO DOMINATE MARKET IN 2029
  • FIGURE 20 SINGE-USE BLOOD COLLECTION DEVICES SEGMENT TO HOLD LARGER SHARE
  • FIGURE 21 HEALTH SCREENING & PREVENTIVE HEALTH TO ACCOUNT FOR LARGER MARKET SHARE TILL 2029
  • FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 AT-HOME BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 INCIDENCE OF DIABETES, 2021 VS 2045 (MILLION INDIVIDUALS)
  • FIGURE 25 AVERAGE SELLING PRICE OF LASER LANCETS, 2024
  • FIGURE 26 PATENT ANALYSIS FOR MICROSAMPLING DEVICES (JANUARY 2014-DECEMBER 2023)
  • FIGURE 27 VALUE CHAIN ANALYSIS OF AT-HOME BLOOD COLLECTION DEVICES MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 28 AT-HOME BLOOD COLLECTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 AT-HOME BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 AT-HOME BLOOD COLLECTION DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF AT-HOME BLOOD COLLECTION DEVICES
  • FIGURE 32 KEY BUYING CRITERIA FOR AT-HOME BLOOD COLLECTION DEVICES
  • FIGURE 33 REVENUE SHIFT IN AT-HOME BLOOD COLLECTION DEVICES MARKET
  • FIGURE 34 AT-HOME BLOOD COLLECTION DEVICES MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 35 NORTH AMERICA: AT-HOME BLOOD COLLECTION DEVICES MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: AT-HOME BLOOD COLLECTION DEVICES MARKET SNAPSHOT
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AT-HOME BLOOD COLLECTION DEVICES MARKET (2023)
  • FIGURE 38 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 40 AT-HOME BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 AT-HOME BLOOD COLLECTION DEVICES MARKET: BRAND COMPARISON FOR LANCETS
  • FIGURE 42 TRAJAN GROUP HOLDINGS LIMITED: COMPANY SNAPSHOT (2023)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!